Corrigendum to “Tetrahydropyridin-4-ylpicolinoylglycines as novel and orally active prolyl hydroxylase 2 (PHD2) inhibitors for the treatment of renal anemia” [Eur. J. Med. Chem. 238 (2022) 114479]
European journal of medicinal chemistry（2023）
关键词
renal anemia”,active prolyl hydroxylase,inhibitors
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要